The good news is Lilly is already reaping the rewards of several new launches, with outstanding performances turned in by diabetes drug Trulicity, immunology treatment Talltz and Emgality for migraines.Among Amgen's growth products already being sold are migraine prevention drug Aimovig's, whose sales reached $306 million last year, and Parsabiv, Prolia, Repatha, Blincyto and Nplate.